Format

Send to

Choose Destination
J Am Coll Cardiol. 2019 Jul 2;73(25):3326-3344. doi: 10.1016/j.jacc.2019.04.034.

Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.

Author information

1
Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York. Electronic address: coi2001@med.cornell.edu.
2
Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-Universität LMU, Munich, Germany.
3
Department of Clinical Neurological Sciences, Western University, London, Ontario, Canada.
4
Institute of Psychiatry and Neurosciences of Paris, INSERM U1266, Université Paris Descartes, Paris, France.
5
Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital and the University of Oxford, Oxford, United Kingdom.
6
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.
7
Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-Universität LMU, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Abstract

Cognitive impairment associated with aging has emerged as one of the major public health challenges of our time. Although Alzheimer's disease is the leading cause of clinically diagnosed dementia in Western countries, cognitive impairment of vascular etiology is the second most common cause and may be the predominant one in East Asia. Furthermore, alterations of the large and small cerebral vasculature, including those affecting the microcirculation of the subcortical white matter, are key contributors to the clinical expression of cognitive dysfunction caused by other pathologies, including Alzheimer's disease. This scientific expert panel provides a critical appraisal of the epidemiology, pathobiology, neuropathology, and neuroimaging of vascular cognitive impairment and dementia, and of current diagnostic and therapeutic approaches. Unresolved issues are also examined to shed light on new basic and clinical research avenues that may lead to mitigating one of the most devastating human conditions.

KEYWORDS:

Alzheimer’s disease; cerebral blood flow; cognitive dysfunction; small vessel disease; stroke

PMID:
31248555
DOI:
10.1016/j.jacc.2019.04.034

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center